InsiderTrades

Form 4 for ELV Elevance Health

Accepted 2023-12-15 00:00:00 ET · period of report 2023-12-14 · accession 0001156039-23-000124 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-12-15 2023-12-14 ELV Todt Blair Williams EVP, CLO, CAO M - OptEx $311.48 +5,492 18.0K +44% +$1.71M
D 2023-12-15 2023-12-14 ELV Todt Blair Williams EVP, CLO, CAO S - Sale+OE $484.02 -5,492 12.5K -31% -$2.66M
D 2023-12-15 2023-12-14 ELV Todt Blair Williams EVP, CLO, CAO M - OptEx $0.00 -5,492 2,746 -67% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-12-14 M A 5,492 $311.48 18,004 D — —
2 Common Common Stock 2023-12-14 S D 5,492 $484.02 12,512 D — —
3 Derivative Employee Stock Option (Right to Buy) 2023-12-14 M D 5,492 $0.00 2,746 D $311.48 · — to 2031-03-01 5,492 Common Stock (F1) The option represents a right to purchase a total of 8,238 shares, and is exercisable in three annual installments of 2,746 shares each, beginning on 3/1/2022, which is the one-year anniversary of the option grant date.